Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hyperfine Inc (HYPR)

Hyperfine Inc (HYPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 120,490
  • Shares Outstanding, K 97,169
  • Annual Sales, $ 12,890 K
  • Annual Income, $ -40,720 K
  • EBIT $ -40 M
  • EBITDA $ -39 M
  • 60-Month Beta 1.09
  • Price/Sales 9.02
  • Price/Cash Flow N/A
  • Price/Book 3.41

Options Overview Details

View History
  • Implied Volatility 199.09% (-22.92%)
  • Historical Volatility 76.55%
  • IV Percentile 14%
  • IV Rank 5.78%
  • IV High 1,431.48% on 04/14/25
  • IV Low 123.51% on 08/26/25
  • Expected Move (DTE 1) 0.0850 (6.91%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 107
  • Volume Avg (30-Day) 85
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 5,881
  • Open Int (30-Day) 4,989
  • Expected Range 1.1450 to 1.3150

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year -0.14
  • Growth Rate Est. (year over year) +42.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8694 +41.48%
on 12/31/25
1.3050 -5.75%
on 01/15/26
+0.3023 (+32.59%)
since 12/15/25
3-Month
0.8500 +44.71%
on 12/03/25
1.5400 -20.13%
on 10/16/25
-0.9700 (-44.09%)
since 10/15/25
52-Week
0.5327 +130.90%
on 05/23/25
2.2200 -44.59%
on 10/15/25
+0.2677 (+27.82%)
since 01/15/25

Most Recent Stories

More News
Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents

The prospective study is designed to evaluate the feasibility and visualization benefits of contrast-enhanced ultra-low-field portable MRI to support an FDA 510(k) submission.

HYPR : 1.2150 (-2.02%)
Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results

Hyperfine Delivers Quarterly Record Revenue of Approximately $5.3 Million in Q4 2025, Representing Transformative Growth of 54% Compared to Prior Quarter; Exiting 2025 with Approximately $35 Million of...

HYPR : 1.2150 (-2.02%)
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulseâ„¢ technology using its proprietary Nanosecond Pulsed Field Ablationâ„¢ (nanosecond PFA or nsPFAâ„¢) energy, today announced...

HYPR : 1.2150 (-2.02%)
OFIX : 14.39 (+0.49%)
SPNC : 38.45 (unch)
AVNS : 12.34 (+3.96%)
PLSE : 14.08 (-1.54%)
SWAV : 334.75 (-0.02%)
Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today...

HYPR : 1.2150 (-2.02%)
Hyperfine Announces Regulatory Approval of the Swoop® System in India

India's Central Drugs Standard Control Organization (CDSCO) has approved the Hyperfine Swoop system, opening a major global market. Commercial launch to begin early 2026.

HYPR : 1.2150 (-2.02%)
Hyperfine Announces FDA Clearance of the First Optive AI™ Software Update with Advanced Diffusion Imaging Capability, Focused on Enhancing Stroke Detection with the Swoop® System

A new multi-direction DWI sequence, the latest Swoop® system software, and the first advancement in Hyperfine’s Optive AI™ software, delivers clearer, higher-quality images for stroke diagnosis, enhancing...

HYPR : 1.2150 (-2.02%)
Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop®...

HYPR : 1.2150 (-2.02%)
Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health

Expansion of initiatives with AI-powered portable MRI will enable evaluation of childhood brain development through neonatal scanning and guide targeted health interventions in underserved communities,...

HYPR : 1.2150 (-2.02%)
Hyperfine, Inc. Reports Third Quarter 2025 Financial Results

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the...

HYPR : 1.2150 (-2.02%)
Hyperfine, Inc. to Announce Third Quarter 2025 Financial Results on November 13, 2025

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop®...

HYPR : 1.2150 (-2.02%)

Business Summary

Hyperfine Inc. is a groundbreaking medical device company which created Swoop(R), first FDA-cleared portable MRI system(TM). Hyperfine Inc., formerly known as HealthCor Catalio Acquisition Corp., is based in GUILFORD, Conn.

See More

Key Turning Points

3rd Resistance Point 1.4433
2nd Resistance Point 1.3467
1st Resistance Point 1.2933
Last Price 1.2150
1st Support Level 1.1433
2nd Support Level 1.0467
3rd Support Level 0.9933

See More

52-Week High 2.2200
Fibonacci 61.8% 1.5755
Fibonacci 50% 1.3764
Last Price 1.2150
Fibonacci 38.2% 1.1772
52-Week Low 0.5327

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar